Search Results for 'study hcv'

study hcv published presentations and documents on DocSlides.

Ledipasvir-Sofosbuvir Retreatment with HCV Genotype 1
Ledipasvir-Sofosbuvir Retreatment with HCV Genotype 1
by danika-pritchard
NIAID Retreatment. Phase . 2a . Treatment. . Exp...
HIV-HCV Coinfection in the era of effective antiviral therapy
HIV-HCV Coinfection in the era of effective antiviral therapy
by mia
Mark Sulkowski, . MD. Professor of Medicine. Medic...
% of Global HCV Seropositive Cases
% of Global HCV Seropositive Cases
by faith
Global epidemiology of hepatitis C virus infection...
Peginterferon alfa-2a +
Peginterferon alfa-2a +
by stefany-barnette
RBV . versus. Interferon alfa. -. 2a + RBV . ACT...
Advances in the Treatment of
Advances in the Treatment of
by danika-pritchard
HCV Genotype 3 and HIV/HCV Coinfection . What's S...
HIV 2015-2016: New Agents, New Strategies
HIV 2015-2016: New Agents, New Strategies
by ellena-manuel
Learning Objectives. EARLY VS DEFERRED ART. The C...
Jennifer Layden, MD, PhD
Jennifer Layden, MD, PhD
by olivia-moreira
Jennifer Layden, MD, PhD Assistant Professor of M...
dress for CorUluhan Sili MD Marmara University Faculty of Medicine D
dress for CorUluhan Sili MD Marmara University Faculty of Medicine D
by cecilia
39 nsan baklk yetmez...
C-EDGE  Co-Infected: Phase 3 Study of
C-EDGE Co-Infected: Phase 3 Study of
by giovanna-bartolotta
C-EDGE Co-Infected: Phase 3 Study of Grazoprevi...
SMV + DCV + SOF Open label
SMV + DCV + SOF Open label
by summer
≥ 18 years. Chronic HCV infection. Genotype 1 or...
Viral hepatitis Best of ILC 2018
Viral hepatitis Best of ILC 2018
by roberts
About these slides. These slides provide highlight...
Daclatasvir - Asunaprevir
Daclatasvir - Asunaprevir
by queenie
-. Beclabuvir in GT1 Patients without Cirrhosis. U...
Viral hepatitis Best of ILC 2019
Viral hepatitis Best of ILC 2019
by stella
About these slides. These slides provide highlight...
Update on Hepatitis C SSHA Conference 2015
Update on Hepatitis C SSHA Conference 2015
by Hiphopkid
Daniel Bradshaw. Locum Consultant . GUM/HIV. Brigh...
Clin Lab 91020131031Clin Lab 20135910311039 Copyright ORIGIN
Clin Lab 91020131031Clin Lab 20135910311039 Copyright ORIGIN
by christina
for Hepatitis C Virus Diagnosis: Usefulness among...
European Journal of General Medicine94
European Journal of General Medicine94
by rose
Prevalence of Hepatitis C Virus The present study...
GP Study Afternoon: Viral Hepatitis
GP Study Afternoon: Viral Hepatitis
by madison
Cockburn Lecture Theatre, St Marys Hospital. Wedne...
LiveR x  Study Eradicating Hepatitis C in Alberta
LiveR x Study Eradicating Hepatitis C in Alberta
by remy477
Cari Egan, RN, BN, MSc, PhD. LiveRx Team. Disclosu...
FISSION Design Objective
FISSION Design Objective
by travis
Non . inferiority. of SOF + RBV : SVR. 12. (. 2-...
What’s New in Hepatitis C
What’s New in Hepatitis C
by debby-jeon
Diana L. . Sylvestre. , MD. University of CA, San...
LDV/SOF 90/400 mg
LDV/SOF 90/400 mg
by aaron
qd. Non-randomised. Open-label. N =. 21. W12. SV...
Elbasvir
Elbasvir
by pamella-moone
+ . Grazoprevir. in . GT 1 . and Chronic Renal ...
SAPPHIRE-I
SAPPHIRE-I
by ellena-manuel
Feld JJ. NEJM . 2014;370:1594-1603. SAPPHIRE-I . ...
Simeprevir
Simeprevir
by alida-meadow
versus . Telaprevir. . with PR in GT1 . ATTAIN ...
PEG alfa-2a +
PEG alfa-2a +
by tawny-fly
RBV . versus. . PEG alfa-. 2a . versus. INF + R...
TURQUOISE-I
TURQUOISE-I
by marina-yarberry
OBV/PTV/r + . DSV . + RBV. OBV/PTV/r + . DSV . + ...
TURQUOISE-II
TURQUOISE-II
by pasty-toler
OBV/PTV/r . + . DSV . + RBV. OBV/PTV/r + . DSV . ...
CURRY
CURRY
by faustina-dinatale
Design. Open-label. CURRY . Study. : SOF + RBV fo...
TURQUOISE-II
TURQUOISE-II
by giovanna-bartolotta
OBV/PTV/r . + . DSV . + RBV. OBV/PTV/r + . DSV . ...
TURQUOISE-I
TURQUOISE-I
by natalia-silvester
OBV/PTV/r + . DSV . + RBV. OBV/PTV/r + . DSV . + ...
HEPATITIS C VIRUS REINFECTION IN PEOPLE WHO INJECT DRUG (PW
HEPATITIS C VIRUS REINFECTION IN PEOPLE WHO INJECT DRUG (PW
by ellena-manuel
G. . Ntetskas. , V. . Papastergiou. , L. . Skorda...
Making the Impossible Possible
Making the Impossible Possible
by phoebe-click
Eradicate Hepatitis C Virus . A pilot of treatmen...
PEG alfa-2a    RBV  versus
PEG alfa-2a RBV versus
by alexa-scheidler
. PEG alfa-. 2a . versus. INF RBV . APRICOT S...
Single arm
Single arm
by min-jolicoeur
Open label. ≥ . 18 years, . HCV genotype 1 to ...
Key Updates from 2023 Conference on Retroviruses and Opportunistic Infections (CROI)
Key Updates from 2023 Conference on Retroviruses and Opportunistic Infections (CROI)
by josephine
Jeffrey Lennox, MD. Professor of Medicine. Emory U...
Special session #10: GRADE: the past 15 and next … years
Special session #10: GRADE: the past 15 and next … years
by felicity
for prognostic evidence . Alfonso Iorio, . MD, PhD...
Viral hepatitis is now recognized as a major public health challenge t
Viral hepatitis is now recognized as a major public health challenge t
by white
that Hepatitis E caused 44,000 deaths in 2015 (acc...
Sparing of opioid-related respiratory depression:
Sparing of opioid-related respiratory depression:
by davis
assessment and analysis. Denham S Ward, MD, PhD. E...